Jim Cramer's Insights on Key Chinese Stocks
On a recent episode of CNBC's “Mad Money,” Jim Cramer expressed his evolving perspective on several stocks, particularly highlighting Bristol-Myers Squibb Company (NYSE: BMY). During the segment, he acknowledged a notable disengagement from this biopharmaceutical giant.
Recent Financial Performance of Bristol-Myers
Bristol-Myers recently reported its third-quarter financial performance, showcasing revenues of $12.22 billion. This figure surpassed analysts’ expectations, which were set at $11.81 billion, marking a healthy 3% increase from the previous year’s performance. Despite these promising results, Cramer indicated a cautionary stance regarding this stock's future.
Cramer's Focus on Chinese Stocks
Shifting focus, Cramer recommended two prominent Chinese companies: Baidu, Inc. (NASDAQ: BIDU) and Alibaba Group Holding Limited (NYSE: BABA). According to Cramer, these two stocks are poised for potential growth, stating, “If you're going to own Chinese stocks, you want to own Alibaba first and Baidu second,” indicating a clear preference for Alibaba.
Upcoming Earnings Reports
In a notable upcoming event, Baidu is expected to release its third-quarter financial results on November 18. Stakeholders are keenly awaiting this report, which may further influence its stock performance.
Brinker International and Its Performance
Cramer also shared insights on Brinker International, Inc. (NYSE: EAT), asserting that it is an appropriate time to invest at its current level. He advised that one should consider acquiring shares at $25, yet he emphasized the need for patience, warning against making additional investments at this pricing.”
Positive Earnings for Brinker
Brinker recently reported quarterly earnings of $1.93 per share, beating analyst expectations of $1.77. The rise in restaurant traffic and effective pricing strategies propelled their profits, more than doubling from $0.95 the previous year. Additionally, revenue increased 18.4% from $1.14 billion, achieving $1.35 billion, slightly exceeding the forecast of $1.33 billion.
Speculative Insights on New Era Energy
Additionally, Jim Cramer commented on New Era Energy & Digital, Inc. (NASDAQ: NUAI). He remarked that investors interested in speculative investments should consider this company, which recently announced entering into a land option purchase agreement for approximately 3,500 acres in Lea County, New Mexico. This development aims to establish a large-scale AI data center campus.
Market Reactions
Recent market activity has indicated significant fluctuations among these stocks:
- Bristol-Myers Squibb shares experienced a 1.2% increase, closing at $47.26.
- Baidu's stock gained 5.1%, closing at $132.32.
- Contrarily, Alibaba faced a slight decline of 0.3%, settling at $165.89.
- Brinker International shares rose by 3.9% to finish at $106.61.
- Meanwhile, shares of New Era Energy dropped by 5.3%, ending at $5.09.
Frequently Asked Questions
What are Jim Cramer's thoughts on Bristol-Myers?
Jim Cramer has expressed a cautious stance on Bristol-Myers, suggesting investors take a step back despite its strong recent earnings report.
Which Chinese stocks did Jim Cramer recommend?
Cramer recommended Baidu and Alibaba, emphasizing that Alibaba is the priority for investors considering Chinese stocks.
What are Baidu's upcoming financial results dates?
Baidu is set to report its third-quarter financial results before the market opens on November 18.
How did Brinker International perform financially?
Brinker surpassed earnings expectations in its latest report, achieving $1.93 per share and significant revenue growth.
What did Cramer say about New Era Energy?
Cramer suggested that New Era Energy could be a good speculative investment, particularly following its recent land acquisition announcement.
